Kubota K - Search Results

1

[New treatment strategy for stage III non-small-cell lung cancer].

Yoh K, Kubota K. Yoh K, et al. Among authors: kubota k. Nihon Rinsho. 2002 May;60 Suppl 5:485-9. Nihon Rinsho. 2002. PMID: 12101719 Review. Japanese. No abstract available.

2

Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer.

Niho S, Ohe Y, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Nishiwaki Y. Niho S, et al. Among authors: kubota k. Lung Cancer. 2002 Feb;35(2):209-14. doi: 10.1016/s0169-5002(01)00328-2. Lung Cancer. 2002. PMID: 11804695 Clinical Trial.

3

[Informed consent in the treatment of lung cancer].

Kubota K. Kubota K. Nihon Rinsho. 2002 May;60 Suppl 5:702-4. Nihon Rinsho. 2002. PMID: 12101767 Review. Japanese. No abstract available.

4

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.

Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y. Niho S, et al. Among authors: kubota k. Cancer Chemother Pharmacol. 2003 Jul;52(1):19-24. doi: 10.1007/s00280-003-0618-8. Epub 2003 Apr 24. Cancer Chemother Pharmacol. 2003. PMID: 12712259 Clinical Trial.

5

Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.

Yoh K, Goto K, Ishii G, Niho S, Ohmatsu H, Kubota K, Kakinuma R, Nagai K, Suga M, Nishiwaki Y. Yoh K, et al. Among authors: kubota k. Cancer. 2003 Sep 1;98(5):926-31. doi: 10.1002/cncr.11606. Cancer. 2003. PMID: 12942558 Free article.

6

Cushing's syndrome associated with adenocarcinoma of the lung.

Yoh K, Kubota K, Nomura M, Niho S, Goto K, Ohmatsu H, Kakinuma R, Nishiwaki Y. Yoh K, et al. Among authors: kubota k. Intern Med. 2003 Sep;42(9):831-3. doi: 10.2169/internalmedicine.42.831. Intern Med. 2003. PMID: 14518671 Free article.

7

Retrospective analysis of safety and efficacy of low-dose docetaxel 60 mg/m2 in advanced non-small cell lung cancer patients previously treated with platinum-based chemotherapy.

Nakamura Y, Kunitoh H, Kubota K, Sekine I, Yamamoto N, Tamura T, Kodama T, Saijo N. Nakamura Y, et al. Among authors: kubota k. Am J Clin Oncol. 2003 Oct;26(5):459-64. doi: 10.1097/01.coc.0000037736.69148.F9. Am J Clin Oncol. 2003. PMID: 14528070

8

Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.

Kubota K, Watanabe K, Kunitoh H, Noda K, Ichinose Y, Katakami N, Sugiura T, Kawahara M, Yokoyama A, Yokota S, Yoneda S, Matsui K, Kudo S, Shibuya M, Isobe T, Segawa Y, Nishiwaki Y, Ohashi Y, Niitani H; Japanese Taxotere Lung Cancer Study Group. Kubota K, et al. J Clin Oncol. 2004 Jan 15;22(2):254-61. doi: 10.1200/JCO.2004.06.114. J Clin Oncol. 2004. PMID: 14722033 Clinical Trial.

9

Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.

Niho S, Ohe Y, Goto K, Ohmatsu H, Matsumoto T, Kubota K, Kakinuma R, Nishiwaki Y. Niho S, et al. Among authors: kubota k. Jpn J Clin Oncol. 2004 Feb;34(2):69-73. doi: 10.1093/jjco/hyh019. Jpn J Clin Oncol. 2004. PMID: 15067098 Clinical Trial.

10

High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.

Yoh K, Niho S, Goto K, Ohmatsu H, Kubota K, Kakinuma R, Nishiwaki Y. Yoh K, et al. Among authors: kubota k. Jpn J Clin Oncol. 2004 Apr;34(4):206-9. doi: 10.1093/jjco/hyh029. Jpn J Clin Oncol. 2004. PMID: 15121757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,670 results

Search Page

Filters